• 13F History

Hamlin Capital Management, LLC

13F Filings History

Latest 13F report
Q4 2024 - Jan 16, 2025
Value $
$4.04B
Signature - Title
Jeremi Roux - General Counsel & Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by Hamlin Capital Management, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Hamlin Capital Management, LLC reported 26 stock holdings with total value $4.04B as of Q4 2024. Top holdings included AVGO, PEG, ARES, MS, and ABBV.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 26 $4.04B +$286M -$272M +$13.5M AVGO, PEG, ARES, MS, ABBV 13F-HR 1/16/2025, 05:08 PM
Q3 2024 25 $3.98B +$553M -$91M +$462M AVGO, PEG, ABBV, ORI, UL 13F-HR 10/24/2024, 12:32 PM
Q2 2024 26 $3.4B +$153M -$103M +$50M AVGO, PEG, ABBV, COP, LAMR 13F-HR 8/13/2024, 05:15 PM
Q1 2024 25 $3.39B +$209M -$240M -$31.3M AVGO, ABBV, COP, LAMR, ARES 13F-HR 5/15/2024, 11:40 AM
Q4 2023 27 $3.18B +$88.3M -$74.4M +$13.9M AVGO, ARES, COP, ABBV, LAMR 13F-HR 1/9/2024, 02:48 PM
Q3 2023 26 $2.91B +$78M -$54.1M +$23.9M AVGO, COP, ABBV, ARES, EPD 13F-HR 10/4/2023, 02:49 PM
Q2 2023 26 $2.98B +$147M -$120M +$27.7M AVGO, ARES, PG, COP, LAMR 13F-HR 7/14/2023, 09:51 AM
Q1 2023 25 $2.87B +$212M -$57.4M +$155M AVGO, ABBV, PG, LAMR, GPC 13F-HR 4/13/2023, 08:12 AM
Q4 2022 27 $2.82B +$120M -$3.07M +$117M GPC, ABBV, AVGO, COP, PG 13F-HR 1/20/2023, 02:35 PM
Q3 2022 28 $2.5B +$259M -$1.37M +$257M GPC, COP, ABBV, EPD, KDP 13F-HR 10/13/2022, 11:55 AM
Q2 2022 29 $2.49B +$250M -$170M +$79.4M ABBV, GPC, JNJ, COP, EPD 13F-HR 7/12/2022, 04:08 PM
Q1 2022 26 $2.84B +$166M -$125M +$41M ABBV, AVGO, COP, ORI, PEG 13F-HR 4/19/2022, 03:34 PM
Q4 2021 28 $2.82B +$295M -$581K +$294M AVGO, ABBV, KEY, GPC, ORI 13F-HR 1/25/2022, 12:23 PM
Q3 2021 28 $2.51B +$37.1M -$20.8M +$16.3M KEY, ORI, AVGO, LAMR, IPG 13F-HR 10/14/2021, 01:28 PM
Q2 2021 28 $2.54B +$185M -$211M -$25.6M ORI, GPC, KEY, ABBV, LAMR 13F-HR 7/14/2021, 04:06 PM
Q1 2021 29 $2.44B +$288M -$254M +$33.7M ORI, GPC, KEY, STLD, AVGO 13F-HR 4/14/2021, 06:09 PM
Q4 2020 29 $2.17B +$267M -$129M +$138M KEY, AVGO, ABBV, GPC, ORI 13F-HR 1/26/2021, 11:11 AM
Q3 2020 28 $1.89B +$343M -$8.69M +$335M VZ, KEY, AVGO, QCOM, PEG 13F-HR 10/13/2020, 12:43 PM
Q2 2020 36 $1.87B +$320M -$122M +$198M CVX, T, VZ, JNJ, ABBV 13F-HR 7/15/2020, 08:59 AM
Q1 2020 42 $1.67B +$550M -$143M +$406M VZ, T, PFE, SNY, ABBV 13F-HR 5/11/2020, 12:23 PM
Q4 2019 41 $2.4B +$135M -$40.1M +$95.3M T, VZ, TGT, BCE, EPD 13F-HR 1/17/2020, 02:37 PM
Q3 2019 37 $2.22B +$103M -$149M -$46.4M T, VZ, TGT, BCE, EPD 13F-HR 10/16/2019, 11:03 AM
Q2 2019 39 $2.33B +$249M -$64.6M +$184M T, VZ, PFE, EPD, BCE 13F-HR 7/22/2019, 04:39 PM
Q1 2019 38 $2.24B +$48.6M -$138M -$89M VZ, T, EPD, TGT, PFE 13F-HR 4/12/2019, 04:23 PM
Q4 2018 47 $2.15B +$393M -$237M +$156M VZ, PFE, QCOM, T, BCE 13F-HR 1/18/2019, 03:14 PM
Q3 2018 42 $2.55B +$121M -$123M -$1.87M PFE, CSCO, T, QCOM, EPD 13F-HR 10/15/2018, 04:19 PM
Q2 2018 39 $2.46B +$408M -$210M +$199M T, STAY, EPD, PFE, CSCO 13F-HR 7/12/2018, 02:09 PM
Q1 2018 42 $2.59B +$409M -$146M +$262M RDSB, INTC, T, CSCO, STAY Restatement 4/18/2018, 05:09 PM
Q4 2017 40 $2.6B +$255M -$103M +$151M CSCO, RDSB, T, GM, PFE 13F-HR 1/31/2018, 03:06 PM
Q3 2017 34 $2.47B +$159M -$53.4M +$105M RDSB, T, CSCO, GM, STAY 13F-HR 10/23/2017, 03:55 PM
Q2 2017 36 $2.4B +$360M -$63.7M +$296M STAY, EPD, PFE, GM, T 13F-HR 7/27/2017, 04:54 PM
Q1 2017 40 $2.37B +$449M -$230M +$219M PFE, RDSB, GM, ETN, CSCO 13F-HR 4/26/2017, 11:47 AM
Q4 2016 43 $2.24B +$157M -$101M +$56.1M GM, RHP, T, KSS, HPT 13F-HR 1/27/2017, 12:18 PM
Q3 2016 41 $2.16B +$246M -$146M +$99.8M GM, CSCO, WY, ABBNY, HPT 13F-HR 10/20/2016, 04:08 PM
Q2 2016 40 $2.06B +$261M -$113M +$147M T, QCOM, RGC, AEO, GM 13F-HR 7/27/2016, 12:16 PM
Q1 2016 38 $1.98B +$239M -$105M +$135M T, ETN, BCE, PEG, RGC 13F-HR 5/2/2016, 10:33 AM
Q4 2015 39 $1.85B +$227M -$26.5M +$201M T, DOW, LAMR, VOD, GM 13F-HR 1/22/2016, 12:06 PM
Q3 2015 41 $1.81B +$242M -$87M +$155M T, BCE, VOD, DOW, LAMR 13F-HR 10/22/2015, 02:26 PM
Q2 2015 41 $1.98B +$177M -$40.8M +$136M T, DOW, VOD, ABBV, BCE 13F-HR 7/16/2015, 01:38 PM
Q1 2015 40 $1.9B +$278M -$126M +$152M DOW, BCE, T, PSO, ETN 13F-HR 4/30/2015, 06:38 AM
Q4 2014 43 $1.79B +$344M -$116M +$229M RHP, T, DOW, VET, SON 13F-HR 1/27/2015, 10:19 AM
Q3 2014 45 $1.67B +$184M -$73.9M +$110M T, RHP, PEG, INTC, GSKXXXX 13F-HR 10/31/2014, 07:59 AM
Q2 2014 45 $1.78B +$272M -$124M +$148M T, BTE, RHP, INTC, PEG 13F-HR 8/13/2014, 08:56 AM
Q1 2014 41 $1.56B +$214M -$117M +$97.3M T, BTE, PEG, RHP, COP 13F-HR 5/5/2014, 01:32 PM
Q4 2013 42 $1.47B DOW, RHP, MRK, INTC, ABBV 13F-HR 1/27/2014, 10:53 AM